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Cardiovascular magnetic resonance imaging (CMR) has become an indispensable clinical
tool for the assessment of morphology, function and structure of the heart muscle. By
exploiting quantification of the effective transverse relaxation time (T2
∗) CMR also affords
myocardial tissue characterization and probing of cardiac physiology, both being in the
focus of ongoing research. These developments are fueled by the move to ultrahigh
magnetic field strengths, which permits enhanced sensitivity and spatial resolution that
help to overcome limitations of current clinical MR systems with the goal to contribute
to a better understanding of myocardial (patho)physiology in vivo. In this context, the
aim of this report is to introduce myocardial T2
∗ mapping at ultrahigh magnetic fields
as a promising technique to non-invasively assess myocardial (patho)physiology. For
this purpose the basic principles of T2
∗ assessment, the biophysical mechanisms
determining T2
∗ and (pre)clinical applications of myocardial T2
∗ mapping are presented.
Technological challenges and solutions for T2
∗ sensitized CMR at ultrahigh magnetic
field strengths are discussed followed by a review of acquisition techniques and
post-processing approaches. Preliminary results derived from myocardial T2
∗ mapping
in healthy subjects and cardiac patients at 7.0 T are presented. A concluding section
discusses remaining questions and challenges and provides an outlook on future
developments and potential clinical applications.
Keywords: magnetic resonance, MRI, ultrahigh field, magnetic susceptibility, MR technology, cardiac physiology,
cardiovascular imaging, myocardial tissue characterization
INTRODUCTION
T2
∗ Sensitized Cardiovascular Magnetic Resonance
Myocardial tissue characterization plays an important role in the diagnosis and treatment of cardiac
diseases. Thanks to its soft tissue contrast and versatility, cardiovascular magnetic resonance
imaging (CMR) has become a vital clinical tool for diagnosis and for guiding therapy of cardiac
diseases [1, 2]. CMR can provide morphologic and functional information as well as insights
into microstructural changes of the heart muscle [2]. Quantitative mapping of MR relaxation
times which govern the MR signal evolution offers the potential of non-invasive myocardial
tissue characterization without the need of exogenous contrast agents. Mapping of the effective
transverse relaxation time T2∗ is the subject of intense clinical interest in CMR. By exploiting the
blood oxygenation level-dependent (BOLD) effect [3], T2∗ sensitized CMR has been proposed as a
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means of assessing myocardial tissue oxygenation and perfusion.
T2
∗ mapping has been shown to be capable of detecting
myocardial ischemia caused by coronary artery stenosis [4], to
reveal myocardial perfusion deficits under pharmacological stress
[5–10], to study endothelial function [11] or to assess breathing
maneuver-dependent oxygenation changes in the myocardium
[12–15]. Preclinical studies have also demonstrated the potential
of T2∗ mapping to detect structural changes in the infarcted heart
muscle and even to distinguish between focal and diffuse fibrosis
[16–18]. In clinical application T2∗ mapping is the method of
choice for quantification of myocardial iron content, an essential
parameter for guiding therapy in patients with myocardial iron
overload [19–23].
The linear increase of susceptibility effects with magnetic field
strength together with the availability of ultrahigh field (B0 ≥
7.0 T) whole body human MR systems has fueled explorations
into myocardial T2∗ mapping at 7.0 T. In this context, the aim
of this report is to introduce the biophysical background of T2∗
as a promising MR biomarker, present challenges and technical
solutions for myocardial T2∗ assessment at ultrahigh magnetic
field strengths, discuss its merits and current limitations, as well
as to show early applications in healthy volunteers and cardiac
patients along with providing a look beyond the horizon.
Biophysics of the Effective Transverse
Relaxation Time T2
∗
The fundamental principle behind T2∗ relaxation is the loss
of phase coherence of an ensemble of spins contained within
a volume of interest or voxel after a radio frequency (RF)
excitation. Unlike T1 relaxation which is based on spin-lattice
interactions or T2 relaxation which is caused by spin-spin
interactions both being inherent properties of tissues in a
magnetic field, T2∗ relaxation includes a tissue inherent part as
well as contributions from external magnetic field perturbations
[24]. Thesemagnetic field inhomogeneities influence the effective
transversal MR relaxation time T2∗ [25, 26]. T2∗ is defined as:
1
T∗2
=
1
T2
+
1
T
′
2
(1)
with T2 being the transverse relaxation time and T′2 representing
magnetic susceptibility related contributions [27].
The most common way of T2∗-weighted imaging is gradient
recalled echo (GRE) imaging. The MR signal magnitude Sm (θ)
created by a spoiled GRE pulse sequence is:
Sm(θ) = S0sin(θ)exp
(
−TE/T∗2
)
[
1− exp (−TR/T1)
]
[
1− cos (θ) exp (−TR/T1)
]
(2)
with S0 representing the spin density, TR the repetition time, TE
the echo time defined by the time between MR signal excitation
and MR signal readout [28], T1 and T2∗ are tissue specific
longitudinal and effective transversal relaxation time constants
and θ is the flip angle about which the magnetization is deflected
by the excitation RF pulse. If TR and T1 are being kept constant
Equation (2) can be simplified to:
Sm(θ) ∝ exp
(
−TE/T∗2
)
(3)
Exploiting this relationship T2∗ can be estimated by acquiring
a series of images at different echo times TE followed by an
exponential fit of the measured signal intensity vs. the echo time
TE. This is commonly realized by using multi echo gradient echo
(MEGRE) pulse sequences, which employ a series of dephasing
and refocusing gradients to quickly acquire a series of T2∗
sensitized images at several echo times as illustrated in Figure 1.
T2
∗ weighted MRI is most sensitive to field perturbations when
TE is equal to T2∗ [29]. Exponential fitting of the signal decay can
be done either for each voxel individually or for the mean signal
within a region of interest. Single voxel fitting is more prone
to noise but provides spatially resolved information in the form
of relaxation maps (Figure 1). Besides mono-exponential fitting
also multi-exponential fitting can be applied, if multiple signal
compartments with different T2∗ relaxation times are expected
within an imaging voxel.
Sm(θ) ∝ S1exp
(
−TE/1T∗2
)
+ S2exp
(
−TE/2T∗2
)
+ . . .
+ Snexp
(
−TE/nT∗2
)
(4)
Here S1, S2, Sn represent the relative volume fractions of
the different compartments with their corresponding effective
transverse relaxation times 1T2∗, 2T2∗, and nT2∗.
T2
∗ relaxation is blood oxygenation level dependent and
provides a functional MR contrast which serves as the basis of
functional brain mapping [3, 26]. The effect results from a change
of the magnetic susceptibility of hemoglobin (Hb) depending on
its oxygenation state. Oxygenated hemoglobin is diamagnetic and
has minor effect on magnetic field homogeneity. Deoxygenated
hemoglobin in contrast is paramagnetic and causes magnetic
field perturbations on a microscopic level resulting in spin
dephasing and signal loss. T2∗-weighted MRI is sensitive to
changes in the amount of deoxygenated Hb (deoxy Hb) per tissue
volume element (voxel). T2∗ changes and corresponding signal
attenuation in T2∗-weighted MR images can hence result from
a change in hemoglobin oxygenation or a change of the tissue
blood volume fraction. The discovery of the BOLD phenomenon
led to the development of functional MRI for mapping of human
brain function, but also inspired research into BOLD imaging and
T2
∗ mapping of the heart [9, 30].
T2
∗ sensitized imaging and mapping are widely assumed to
provide a surrogate of oxygenation. Yet the factors impacting the
transverse relaxation rate other than oxygenation are numerous
including macroscopic magnetic field inhomogeneities, blood
volume fraction and hematocrit [31]. Considering a biologic
tissue with a specific blood volume fraction BVf, a hematocrit Hct,
and a local blood oxygen saturation So2, T2∗ can be modeled as:
1
T∗2
=
1
T2
+ γ |1B| =
1
T2
+ BVf · γ ·
4
3
· π ·1χ0 ·Hct · (1− So2)B0 + γ |1Bother|
(5)
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FIGURE 1 | T2
* decay and T2
*-weighted image contrast. Top left: Plot of signal intensity over echo time for T2
* weighted imaging. Bottom: Example of
mid-ventricular short axis views of the human heart obtained at 7.0 T. Images were acquired with increasing T2
*-weighting (from left to right). Top right: Corresponding
myocardial T2
* map superimposed to a FLASH CINE image.
with γ |1Bother| representing additional magnetic field
inhomogeneities such as macroscopic field changes [32, 33] and
1χ0 = 3.318 ppm being the magnetic susceptibility difference
of fully oxygenated and fully deoxygenated hemoglobin (in SI
units) [34]. When tissue blood volume fraction, hematocrit
level and macroscopic B0 contributions are known and echo
times are greater than a characteristic time Equation (5) can be
employed to non-invasively estimate tissue oxygenation using
MRI [33]. It should be noted that a reduction in the tissue blood
volume fraction can result in a T2∗ increase which could be
misinterpreted as an oxygenation increase and hence result in
premature conclusions if the effect of blood volume fraction is
not taken into account [35]. If all the parameters are considered
correctly, T2∗ can serve as a non-invasive means to probe
physiology in vivo. It should be noted that T2 changes, e.g.,
caused by alterations in tissue water content or distribution are
also reflected in T2∗ and hence should be considered as potential
confounders.
Benefits of Myocardial T2
∗ Mapping at
Higher Magnetic Field Strengths
The magnetization M of a material in response to an applied
magnetic field is given by its magnetic susceptibility χ and the
strength of the applied magnetic field H:
M = χH (6)
This relationship results in a linear increase of magnetic field
perturbations induced by microscopic susceptibility changes—
the main driving force behind T2∗ decay—when moving to
higher magnetic fields. The effect has been confirmed for
myocardial R2∗ (R2∗ = 1/T2∗) in vivo rendering T2∗ mapping
at ultrahigh magnetic fields (B0 ≥ 7.0 T) particularly appealing
[36] (Figure 2). The enhanced susceptibility effects at 7.0 T
may be useful to extend the dynamic range of the sensitivity
for monitoring T2∗ changes and to lower their detection level.
Another advantage of performing T2∗ weighted imaging and
mapping at ultrahigh magnetic field strengths (UHF) is that the
signal-to-noise ratio (SNR) gain achieved at higher fields can be
used to improve the spatial resolution [37, 38]. This reduction
in voxel sizes lowers the impact of macroscopic magnetic
field gradients on intra-voxel dephasing and hence T2∗ which
otherwise can be a concern especially in the vicinity of strong
susceptibility transitions. Transitioning to higher magnetic field
strengths runs the additional benefit that the in-phase inter-
echo time governed by the fat-water phase shift between the
water and main fat peak of about 3.5 ppm is reduced from
approximately 4.5ms (223Hz) at 1.5 T to 0.96ms (1,043Hz) at
7.0 T. This enables rapid acquisition of multiple echoes with
different T2∗ sensitization and facilitates high spatio-temporally
resolved myocardial CINE T2∗ mapping of the human heart
[39]. Taking advantage of this technique, T2∗ mapping at
ultrahigh magnetic fields has been suggested as a means to
probe myocardial physiology and to advance myocardial tissue
characterization.
CHALLENGES AND TECHNICAL
SOLUTIONS FOR CARDIAC MRI AT
ULTRAHIGH MAGNETIC FIELDS
Enabling Radio Frequency Antenna
Technology
Imaging the heart—a deep-lying target region surrounded by
the lung within the large volume of the thorax—at ultrahigh
magnetic field strengths poses a severe challenge due to the
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FIGURE 2 | Relation of ventricular septal R2
* and static magnetic field
strength. Myocardial R2
* increases linearly with magnetic field strength
(adapted from Meloni et al. [36] with permission from John Wiley and Sons).
short wavelength of the proton resonance frequency in tissue
(λmyocardium ≈ 12 cm at 7.0 T). As a result, non-uniformities in
the transmission field (B+1 ) can cause shading, massive signal
drop-off or signal void in the images up to non-diagnostic image
quality. These constraints were reported being a concern in CMR
at 3.0 T [40] and were to be expected to pose a major obstacle for
CMR at UHF.
A plethora of reports have evolved during the past years
introducing technical innovations in RF antenna design to
overcome non-uniform transmission fields. Local transceiver
(TX/RX) and multi-channel transmission arrays in conjunction
with multi-channel local receive arrays have been suggested
as possible solutions. Eminent developments put building
blocks to use consisting of stripline elements [41–45], electrical
dipoles [45–51], dielectric resonant antennas [52], slot antennas
[53], and loop elements [54–59]. Rigid, flexible and modular
configurations have been exploited. Irrespective of the building
block technology, a trend toward higher numbers of transmit and
receive elements can be observed with the purpose to advance
anatomic coverage [47, 54–59] and to add degrees of freedom for
transmission field shaping [60].
Figure 3 compiles developments of loop element based
transceiver configurations optimized for CMR at 7.0 T. A 4-
channel TX/RX [55] (Figure 3A) and an 8-channel TX/RX [58]
(Figure 3B) one-dimensional array were reported and extended
to a 16-channel two-dimensional design [56] (Figure 3C). A
modular 32-channel TX/RX [59] (Figure 3D) array further
exploited the two-dimensional building block layout.
Electric dipoles hold the benefit of a linearly polarized current
pattern with the RF energy being directed perpendicular to the
dipole along the Poynting vector to the subject. As a consequence,
the excitation field is symmetrical and uniform and comes with
ample depth penetration [48] which renders electric dipoles
particularly promising for MR of the upper torso and the heart.
This property formed the starting point for explorations into
electric dipole configurations [46–48, 50, 51]. Due to their
length straight dipole elements are unfavorable if not unfeasible
for high density multi-dimensional transceiver coil arrays [48].
To address this issue, the fractionated dipole concept splits
the dipole’s legs into segments interconnected by capacitors or
inductors to achieve dipole shortening. Reduced SAR levels,
moderate coupling and homogeneous B+1 have been reported
for prostate imaging using an eight-element array consisting of
fractionated dipoles [51]. A combined 16-channel loop-dipole
transceiver array exploiting the fractionated dipole antenna
design provided cardiac images acquired at 7.0 T exhibiting
high SNR and B+1 transmit efficiency [50]. As an alternative,
shortening of the effective antenna length can be achieved
for a bow tie shaped λ/2-dipole antenna by immersing it in
D2O. Following this achievement electric dipole configurations
optimized for UHF-CMR have been reported using 8 or 16
bow tie antenna building blocks [47] (Figures 3E,F). As a result
of these research efforts, dedicated RF antenna arrays are now
available which facilitate cardiac MRI at 7.0 T with rather
uniform signal intensities across the heart.
In summary, explorations into enabling RF antenna
technology underlined the benefits of many-channel
high-density arrays for UHF-CMR.
Ancillary Devices for Cardiac
Synchronization
Imaging the heart requires synchronization of the data
acquisition with the cardiac cycle. Magneto hydrodynamic
(MHD) effects severely disturb the electrocardiogram (ECG)
[61–63] commonly applied for cardiac triggering and gating
at clinical field strengths [64–66] (Figure 4). Distortions of the
ECG’s S-T segment are caused by the increased MHD impact
during systolic aortic flow [67]. The S-T elevation might be
mis-interpreted as an R-wave. Consequently, image quality is
impaired due to the mis-detected onset of a cardiac cycle. The
propensity to MHD effects is pronounced at ultrahigh magnetic
field strengths [42, 68, 69]. An MR-stethoscope has been
proposed as an alternative to ECG gating and triggering putting
acoustic signals to use which have been reported to be immune
to interferences with electromagnetic fields. With this practical
solution the first heart tone of the phonocardiogram is detected,
which marks the onset of the acoustic cardiac cycle. The minor
latency between the onset of the electrophysiological cardiac
activity and the onset of the acoustic cardiac activity allows
prospectively triggered and retrospectively gated acquisitions.
Acoustic triggering can hence be used with all pulse sequences
that support ECG triggering without the need of sequence
adjustments. Reliable trigger information has been demonstrated
when using acoustic cardiac triggering and gating for UHF-
CMR (Figure 4) [61, 68, 70]. Further alternatives for cardiac
synchronization include post-processing of the ECG signal to
reduce MHD induced distortions of the ECG trace [71, 72].
Wideband radar, magnetic field probes or optical systems have
been proposed for physiological monitoring [73–75].
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FIGURE 3 | Examples of multi-channel transceiver arrays tailored for cardiac MR at 7.0 T. Top: Photographs of cardiac optimized 7.0 T transceiver coil arrays
including (left to right) (A) a four-channel, (B) an eight channel, (C) a 16 channel and (D) a 32 channel loop array configuration together with an (E) eight channel and
(F) 16 channel bow tie antenna array. For all configurations the RF elements are used for transmission and reception. Center and bottom: Four chamber and short axis
views of the heart derived from 2D CINE FLASH acquisitions using the RF coil arrays shown on the left and a spatial resolution of (1.4 × 1.4. × 4.0) mm3 (from
Niendorf et al. [113] with permission from John Wiley and Sons).
T2
∗ Imaging Techniques
T2
∗ sensitized imaging and mapping is commonly performed
employing gradient echo imaging independent of magnetic field
strength. To decrease acquisition times multi echo gradient
echo techniques (MEGRE) acquiring multiple echoes after
each RF excitation instead of only one echo per repetition
time TR are recommended for fast T2∗ mapping (Figure 5A,
top). For myocardial T2∗ mapping cardiac triggered segmented
acquisitions are commonly performed in end-expiratory breath
hold conditions to avoid respiratory and cardiac motion and to
reduce related macroscopic B0 field fluctuations.
The used echo times should be adapted to sufficiently cover
the T2∗ decay. As the contributing fat and water signal are
oscillating at different frequencies mapping algorithms must
either account for or compensate the varying signal intensity
from fat and water. Acquiring T2∗-weighted images at times
when fat and water are equally contributing to the MR signal
(in-phase) is the simplest approach to achieve this goal. At 7.0 T
this is the case for echo times being a multiple of about 0.96 ms
due to the chemical shift between the main fat and water peaks
of approximately 3.5 ppm (1,043Hz). Acquisition of echoes with
an inter-echo spacing of ∼1 ms constitutes a challenge due to
gradient amplitude and rise time limitations, especially when
large acquisition matrix sizes are used. Alternatively, interleaved
acquisitions can be performed by distributing the acquisition
of neighboring echoes across multiple excitations (Figure 5A,
middle). This approach permits low inter-echo spacing even
for large matrix sizes but results in longer scan times since
more than one TR is required to acquire a full T2∗ decay
series. While T2∗ mapping at clinical field strengths is limited to
single cardiac phase acquisitions, CINE T2∗ mapping covering
the entire cardiac cycle is feasible at UHF [39]. This advanced
capability is facilitated by two benefits of UHF-MR. First, due
to transversal relaxation time shortening at ultrahigh magnetic
fields, TE can be limited to a range of approximately TE =
0 ms to TE = 15 ms to properly sample the myocardial T2∗
decay. This approach is beneficial for reducing the duration of the
gradient echo trains compared to lower magnetic field strengths
enabling breath held multi echo CINE acquisitions. Second, the
reduced in-phase echo spacing permits acquisition of a sufficient
number of echoes needed to cover the signal decay and to
provide an appropriate number of data points for signal fitting.
Interleaving of echo times can be combined with distributing
the acquisition across multiple breath-holds to ease gradient
constraints and limit breath-hold durations for each acquisition
(Figure 5A, bottom). All described acquisition strategies are
capable of producing T2∗ maps of similar fidelity as illustrated
in Figure 5B for a homogenous MR phantom resembling the
relaxation properties of humanmyocardium. To reduce the effect
of macroscopic magnetic field gradients on spin dephasing and
T2
∗, small voxel sizes are preferable. Of course this preference
has to be balanced with SNR requirements for accurate mapping
which can be challenging particularly at lower magnetic field
strengths. Figure 5B compares the effect of slice thickness onT2∗.
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FIGURE 4 | Comparison of ECG and acoustic triggering or gating showing system schemes (left), signal traces acquired in the isocenter of a 7.0 T magnet for 18
cardiac cycles (middle) and corresponding four chamber views acquired at 7.0 T with the respective approaches (right). The ECG gated image shows severe artifacts
due to incorrect cardiac synchronization, while the acoustically triggered image reveals decent image quality with good blood myocardium contrast and clear
delineation of subtle structures.
While maps acquired with slice thicknesses of 6 mm or above
show intra-voxel dephasing and T2∗ decrease pronounced at the
phantom interfaces, this effect is mitigated for slice thicknesses of
4 mm or less resulting in a more uniform T2∗ map. Employing
the described multi-breath hold CINE technique at 7.0 T, CINE
T2
∗ mapping with more than 20 cardiac phases is feasible which
allows monitoring of myocardial T2∗ across the cardiac cycle
(Figure 6).
In contrast to gradient echo imaging Rapid Acquisition with
Relaxation Enhancement (RARE) imaging is rather insensitive
to B0 inhomogeneities, provides images free of distortion due
to the use of RF refocused echoes and inherently suppresses
blood signal. Cardiac RARE imaging at 7.0 T has been shown
to be feasible [76]. These results—in conjunction with the
challenges and opportunities of myocardial T2∗ mapping at
UHF—build the starting point for explorations into RARE based
T2
∗ mapping of the heart at 7.0 T. An evolution time τ inserted
after the excitation RF pulse accrues an additional phase to the
magnetization that reflects the T2∗ effect [77] (Figure 7A). As a
consequence, the Carr-Purcell-Meiboom-Gill condition cannot
be met and destructive interferences between odd and even
echo groups configuring the signal in RARE imaging impair
the image [78, 79]. Measures to account for this effect include
displaced RARE [77, 80], avoiding interferences by discarding
one of both echo groups, resulting in an SNR loss of factor two.
Split-echo variants hold the benefit that the full available signal
is maintained [81] (Figure 7A). A series of T2∗ weighted images
derived from RARE imaging using evolution times τ ranging
from 2 to 14 ms is displayed in Figure 7B and demonstrates that
the geometric integrity of the RARE images is maintained over
the range of applied T2∗ weighting. The corresponding T2∗ map
is shown in Figure 7C. MEGRE imaging results are shown for
comparison and exhibited less myocardium to blood contrast due
to the bright-blood characteristic of the technique. Consequently,
the delineation of the myocardium in the corresponding T2∗
map (Figure 7C) is more challenging compared to the RARE
based T2∗ map. The average effective transversal relaxation time
derived from RARE imaging compares well to values previously
reported for MEGRE approaches [39]. The concerns of RF
power deposition and RF non-uniformity of RARE imaging
were offset in this preliminary study. Split-echo RARE hence
holds the potential to provide an alternative for T2∗ mapping
free of geometric distortion and with high blood myocardium
contrast.
Frontiers in Physics | www.frontiersin.org 6 June 2017 | Volume 5 | Article 22
Huelnhagen et al. Myocardial T2
∗ Mapping at Ultrahigh Field
FIGURE 5 | Acquisition schemes used for T2
* weighted imaging/mapping and
corresponding T2
* maps. (A) (I) multi echo gradient echo (MEGRE)
acquisition, (II) multi shot (MS) interleaved multi gradient echo acquisition,
(III) multi breath hold CINE (MB-CINE) interleaved multi gradient echo
acquisition. (B) Comparison of T2
* maps derived from a homogenous
phantom resembling myocardial tissue acquired using the three different
approaches and slice thicknesses from 8 to 2.5 mm. All acquisition strategies
provide similar T2
* maps. Through plane dephasing is reduced for lower slice
thickness (adapted from Hezel et al. [39].)
Assessment and Control of Main Magnetic
Field Homogeneity
The complex MR signal S (r, t) obtained by a gradient echo
technique at a location r and time t after signal excitation is given
by:
S(r, t) = Sˆ(t) · e−iφ(r,t), Sˆ(t) ∝ S0 · e
− t
T∗2 (7)
Sˆ (t) is the magnitude signal, i is the imaginary unit and φ is the
signal phase. The signal phase φ can be written as a function of
spatial location and time [82]:
φ(r, t) = φ0(r)− γ ·1B(r) · t (8)
with γ being the gyromagnetic constant of the nucleus (for 1H
γ = 2.675×108 rad/s/T) and1B (r) representing local magnetic
field deviations with regard to the main magnetic field strength.
φ0 (r) represents a constant receiver phase offset, while the time-
dependent phase component γ · 1B(r) · t is dominated by the
deviation from the static magnetic field and evolves linearly
over time [83]. Assuming there are no other external sources
of dephasing such as, e.g., motion or flow, the signal phase φ
serves as a direct measure of deviations from the main magnetic
field B0.
Equation (1) can be approximated as:
1
T∗2
=
1
T2
+
1
T
′
2
∼=
1
T2
+ γ |1B| (9)
if a linear B0 gradient within a voxel is assumed [32]. This
assumption is justified for typical voxel sizes used in cardiac
T2
∗ mapping at 7.0 T with an in-plane spatial resolution
of about 1mm and a slice thickness of 2–4mm [39, 84].
|1B| in Equation (9) includes microscopic magnetic field
perturbations resulting from microstructural changes, blood
oxygenation changes, iron accumulation etc. which are of
diagnostic interest as well as macroscopic field changes, e.g.,
due to magnet imperfections or strong susceptibility transitions
at air tissue interfaces. This dependency highlights the need
to monitor and possibly compensate B0 inhomogeneities when
performing T2∗ assessment to make sure that T2∗ decay reflects
microscopic susceptibility changes rather than macroscopic field
perturbations.
By acquiring images at two echo times (TE), the local magnetic
field variations can be calculated at each voxel by making use of
Equation (8):
1B (r) =
φ (r,TE2)− φ (r,TE1)
γ (TE2 − TE1)
(10)
where 1B (r) is given in Tesla. This procedure is referred to
as B0 mapping. It is also very common to represent local
magnetic field variations in Hz by means of off-center frequency
maps:
1BHz (r) =
φ (r,TE2)− φ (r,TE1)
2π (TE2 − TE1)
(11)
B0 shimming describes the process of adjusting the main
magnetic field B0 to improve macroscopic field homogeneity.
Active shimming refers to the adjustment of the main magnetic
field by making use of dedicated shim coils thereby creating
compensatory magnetic fields up to the 5th order of spherical
harmonics [85]. Despite the existence of 5th order shim systems,
most scanners provide only shim coils up to 2nd order.
Active shimming options include fixed shim current settings or
shimming modes based on an individual B0 map acquired for
a specific subject. For cardiac B0 shimming a cardiac triggered
field map acquisition is recommended to avoid motion artifacts.
Usually a shim volume of interest is defined covering the target
anatomy. Ideally the target volume should cover a small region
of interest like the heart, to achieve satisfying field homogeneity
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FIGURE 6 | Example of cardiac phase resolved myocardial T2
* mapping of a short axis view of a healthy volunteer (10 out of 20 phases shown). Spatial resolution =
(1.1 × 1.1 × 4.0) mm3. Temporal resolution = 37 ms. T2
* variations can be observed across the cardiac cycle. TT indicates the time since the trigger.
even when a limited order of shim coils is available. Figure 8
compares B0 homogeneity in the heart of a healthy subject at
7.0 T after applying a volume shim (Figure 8A, top), which
is focused only on the heart and after applying a global shim
(Figure 8A, bottom) which includes the entire field of view.
Volume selective shimming was found to lead to a significant
improvement in macroscopic B0 homogeneity vs. global B0
shimming (Figure 8B) [39].
Due to increased susceptibility effects, magnetic field
inhomogeneities are pronounced at higher magnetic field
strengths [36] (compare Equation 6). This is often a concern
for T2∗ weighted imaging or T2∗ mapping at high and ultrahigh
magnetic fields. However, by employing dedicated shimming
approaches, a mean peak-to-peak off-resonance frequency across
the human heart of 80Hz [39] was reported at 7.0 T. For the left
ventricle a B0 peak-to-peak difference of approximately 65Hz
was observed at 7.0 T after volume selective shimming [39].
These results were obtained with a second order shim system
so that the same level of B0 uniformity reported here should
be achievable with the current and next generation of 7.0 T
scanners. The frequency shift across the heart obtained at 7.0 T
compares well with previous 3.0 T studies which reported a
peak-to-peak off-resonance variation of (176 ± 30) Hz over the
left ventricle and (121 ± 31) Hz over the right ventricle with
the use of localized linear and second-order shimming [86]. The
use of an enhanced locally optimized shim algorithm, which is
tailored to the geometry of the heart, afforded a reduction of
the peak-to-peak frequency variation over the heart from 235
to 86Hz at 3.0 T [87]. Another study showed a peak-to-peak
off-resonance of (71 ± 14) Hz for short axis views acquired at
1.5 T [88] using global shimming. While dedicated shim routines
revealed competitive results at 7.0 T vs. lower magnetic fields
strength, the feasibility of using these approaches in a clinical
setting remains to be investigated.
The achievement of macroscopic B0 homogeneity across
the heart at 7.0 T which is competitive with that obtained at
lower magnetic field strengths provides encouragement to pursue
susceptibility-based myocardial T2∗ mapping at ultrahigh fields.
Yet, with the arrival of CINE T2∗ mapping techniques enabled
by 7.0 T [39], also temporal B0 fluctuations across the cardiac
cycle and their implications on T2∗ need to be considered for a
meaningful interpretation of dynamic T2∗-weighted acquisitions.
Temporal B0 variation across the cardiac cycle was reported to be
negligible at 1.5 T [89], but due to the increase of susceptibility
effects at ultrahigh fields further investigations of this potential
confounder were required at 7.0 T. It should be noted that
T2
∗-weighted contrast is determined by magnetic field gradients
rather than absolute magnetic field strength, thus it is essential to
investigate the change of these gradients over the cardiac cycle.
This was done at 7.0 T by assessing macroscopic B0 gradients
across the cardiac cycle in the heart of healthy volunteers together
with high temporal and spatial resolution T2∗ maps [84, 90]. T2∗-
weighted series of short-axis views were acquired using aMEGRE
CINE approach (Figure 9A, top) for cardiac phase resolved B0
and T2∗ mapping. Temporally-resolved B0 maps of the heart
were calculated (Figure 9A, middle). Macroscopic intra-voxel
field gradients were determined for each cardiac phase and their
fluctuations were analyzed across the cardiac cycle. The septal in-
plane gradients were found to be significantly larger compared
to through-plane gradients within a voxel [with a mean in-
plane field dispersion of (2.5 ± 0.2) Hz/mm against the a mean
through-plane field dispersion of (0.4± 0.1) Hz/mm] [91].
In order to evaluate how these B0 gradients affect T2∗
measurements, the B0 gradient-induced change of T2∗
represented as 1T2∗ was estimated [84, 91]. Figure 9B
shows the plot of mean septal T2∗, intra-voxel B0 gradients
and estimated gradient-induced 1T2∗ over the cardiac cycle
averaged over a group of healthy subjects. The mean septal
T2
∗ per cardiac phase was found to vary over the cardiac cycle
in a range of approximately 23% of the total mean T2∗ for all
phases. Yet, the temporal range of mean 1T2∗ induced by the
calculated intra-voxel macroscopic B0 gradients represented
Frontiers in Physics | www.frontiersin.org 8 June 2017 | Volume 5 | Article 22
Huelnhagen et al. Myocardial T2
∗ Mapping at Ultrahigh Field
FIGURE 7 | RARE-based myocardial T2
* mapping at 7.0 T. (A) Basic pulse sequence diagram of T2
* weighted split-echo RARE. T2
* weighting is introduced into
RARE by adding an evolution time τ after the excitation RF pulse. The dephasing gradient in frequency encoding direction is imbalanced (marked in gray) to avoid
destructive interferences between odd and even echo groups. (B) T2
*-weighted split-echo RARE images of a short axis view employing evolution times ranging from τ
= 2 ms to τ = 14 ms (left). MEGRE images obtained with echo times ranging from 2 to 14 ms (right). For improved visualization, the images do not exhibit identical
windowing over the range of increasing susceptibility weighting. The myocardium was delineated and the contour is shown in the images with minimal τ/TE. (C) T2
*
maps derived from data in shown in (B) are depicted for the RARE (top) and the GRE (bottom) approach. The contours defined in the images with minimal τ/TE were
copied to the T2
* maps for better delineation of the myocardium.
only a 5% change of total mean T2∗. The remaining 18% were
suggested to reflect microscopic B0 gradient changes (potentially
caused by physiological events) rather than macroscopic field
inhomogeneities [84, 91].
In summary it can be concluded that if careful shimming is
applied, macroscopic magnetic field inhomogeneities are not of
concern for myocardial T2∗ mapping even at a magnetic field
strength as high as 7.0 T. Also dynamic B0 fluctuations across
the cardiac cycle can be considered negligible in the ventricular
septum. These findings represent an essential prerequisite for
meaningful interpretation of myocardial T2∗ and its dynamics
across the cardiac cycle.
Data Post-processing
The effective transverse relaxation time T2∗ can be estimated by
fitting an exponential function to a series of gradient echo images
with different T2∗ weighting, i.e., different echo times (compare
Equations 3, 4; Figure 1). A common way of calculating such
a fit by avoiding non-linear fitting procedures, is to calculate
the natural logarithm of the acquired signal intensities and
apply a least squares linear fit to the resulting data. This
procedure is fast and produces the best solution to represent
the linearized data in a least squares sense. Further to this,
non-linear fitting approaches which can be applied directly
to the measured data are available. The algorithms employ
non-linear models in conjunction with optimization algorithms
like Levenberg-Marquardt or Simplex [92]. Iterative non-linear
fitting algorithms can provide improved fitting accuracy, but can
be prone to careful initialization. Fast linear fitting can be used
to initialize non-linear fitting algorithms leading to increased
robustness and faster convergence. Irrespective of the kind of
employed fitting procedure, care should be taken for voxels
with intensities being at the noise level and hence potentially
deteriorating the fit quality. Low SNR is a common problem
particularly for myocardial T2∗ mapping where acquisition times
are often limited by the tolerable breath hold time. Such voxels
should either be excluded from fitting—a procedure referred to
as truncation—or included in the fit model as a constant noise
term.
Most commercial MR systems support exponential fitting
algorithms as part of the systems’ software, but using customized
fitting routines is often beneficial for research. First, it is often
unclear what model or fitting approach is used by commercial
software and how good the fit quality was, i.e., how well the
fit describes the measured data. Measures like the coefficient
of determination R2 or the standard deviation of the T2∗ fit
[93] should be used to evaluate the reliability of the results.
Taking fitting results for granted without considering fit quality
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FIGURE 8 | Comparison between volume and global B0 shimming in the heart of a healthy volunteer at 7.0 T. (A) left: placement of the adjustment volume in a
magnitude image. (A) right: B0 maps with the region of interest (red) and a profile across the heart through the ventricular septum (dashed black line) overlaid. (B) Plot
of the histogram detailing the distribution of B0 in the ROI outlined in the B0 maps (top) and plots along the profile in the B0 map (bottom) of volume selective (black)
and global (red) shim. A clear improvement of field inhomogeneity can be observed after volume selective shimming indicated by a narrowing of the histogram and a
flattened B0 profile.
FIGURE 9 | Spatial and temporal variation of macroscopic intra-voxel B0 gradients in the in vivo human heart. (A) Magnitude images of a short-axis view (top),
in-plane macroscopic B0 maps (middle) and intra-voxel macroscopic B0 gradient maps (bottom) over the cardiac cycle. (B) Mean septal T2
* (blue), intra-voxel B0
gradient (black) and estimated 1T2
* caused by this B0 gradient (red) over the cardiac cycle, averaged among a group of healthy volunteers. Temporal macroscopic
magnetic field changes over the cardiac cycle are minor regarding their effects on T2
* (from Huelnhagen et al. [84] with permission from John Wiley and Sons).
may lead to wrong results and eventually wrong conclusions.
Second, tailored fitting procedures offer the freedom to select the
most appropriate fit model, optimization approach, truncation
threshold, etc. for the particular research question. Depending
on the kind of application, it may for example make sense to
use a bi-exponential or multi-exponential model instead of a
mono-exponential approach.
In contrast to qualitative signal intensity images, relaxation
maps like T2∗ maps offer the advantage of providing quantitative,
comparable results. Yet, effects like B0 inhomogeneities or signal
noise can impair the assessment of T2∗ and lead to wrong
results. Dedicated B0 shimming approaches help to mitigate
the impact of macroscopic magnetic field inhomogeneities.
A reduction in voxel size can further reduce the influence
of B0 gradients on T2∗ (Figure 5B). Yet, reducing voxel size
results in an SNR loss, which can induce poor fit quality
offsetting the benefit of the smaller voxel size. While a
reduction in SNR might be counteracted by signal averaging
and increasing acquisition times in static acquisition situations
(e.g., MRI of the brain), it is often not feasible in cardiac
applications, where acquisitions need to be synchronized with
the cardiac cycle and where it is common to utilize breath held
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FIGURE 10 | Impact of spatially adaptive non-local means (SANLM) noise filtering on T2
* maps of a mid-ventricular short axis view of the heart. Left: Original and
SANLM filtered signal magnitude images of the first echo (TE = 2.04 ms) of a series of multi-echo gradient echo images. Center: Corresponding T2
* maps. Right: T2
*
standard deviation maps illustrating the precision of the T2
* maps. By applying the noise filter, an average decrease in T2
* fit standard deviation of about 30% in the
left ventricular myocardium was achieved.
conditions constraining the viable window of data acquisition
to few seconds. This issue is even further pronounced in
patients suffering from cardiac diseases and for acquisitions
at high spatial or temporal resolution such as CINE T2∗
mapping.
Image de-noising presents a viable solution to address this
constraint and allows the use of small voxel sizes while still
achieving acceptable fit quality. Powerful de-noising approaches
like non-local means filtering [94] are readily available and can
greatly improve SNR with minimal loss of information. De-
noising of the T2∗ maps is not recommended, because low fit
quality of fitting noisy data can result in large T2∗ errors that
might even be enlarged or spread out by filtering. Also algorithms
that estimate the noise level from the provided data will fail
if presented with T2∗ maps. Filtering of the magnitude images
prior to fitting instead represents a robust way of improving fit
quality and has been shown to increase T2∗ fitting accuracy and
precision [84, 95, 96] without the risk of introducing large errors.
Figure 10 illustrates an example of how T2∗ mapping can benefit
from noise filtering. Here a 30% reduction of T2∗ fit standard
deviation was achieved by noise filtering. For applications where
SNR is limited such as myocardial T2∗ mapping, image de-
noising approaches provide a good solution to improve mapping
results.
INSIGHTS FROM IN VIVO HUMAN
MYOCARDIAL T2
∗ MAPPING AT
ULTRAHIGH FIELDS
The technological andmethodological developments in ultrahigh
field CMR outlined above, permit for the first time the in
vivo assessment of temporal myocardial T2∗ changes across the
cardiac cycle. Initial studies have applied these advances to gain
first insights from using this technique in healthy volunteers
and patients suffering from cardiovascular diseases to investigate
their feasibility and potential [39, 84].
CINE Myocardial T2
∗ Mapping in Healthy
Subjects
A first study systematically investigating the temporal changes
of myocardial T2∗ across the cardiac cycle in healthy subjects
at 7.0 T was published in 2016 [84]. The authors analyzed the
time course of myocardial T2∗ throughout the cardiac cycle
along with basic myocardial morphology, i.e., ventricular septal
wall thickness and inner left ventricular radius as potential
confounders of T2∗. The results demonstrated that myocardial
T2
∗ obtained correlates linearly with the myocardial wall
thickness [84], (Figure 11). The same study also showed that
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FIGURE 11 | Relationship of mean ventricular septal wall thickness and mean
septal T2
* in a group of healthy volunteers at 7.0 T. One data point
corresponds to one cardiac phase. Septal wall thickness and T2
* are linearly
correlated. The result of linear regression is plotted in red. Error bars indicate
SEM.
T2
∗ in the ventricular septum changes periodically across the
cardiac cycle [84]. It increases in systole—the part of the cardiac
cycle when the ventricles contract—and decreases in diastole—
the part of the cardiac cycle when the heart relaxes and refills
with blood (Figure 12A). The mean systole to diastole T2∗
ratio was found to be approximately 1.1. Despite the numerous
factors affecting T2∗ such as blood volume fraction, hematocrit
etc., myocardial T2∗ is still often regarded as surrogate for
tissue oxygenation. Interpreting T2∗ to reflect tissue oxygenation,
the observed systolic T2∗ increase would imply an increase in
left myocardial oxygenation during systole. This is contrary to
physiological knowledge. Instead, changes in myocardial blood
volume fraction induced by variations in blood pressure and
resulting myocardial wall stress are believed to be responsible
for the observed cyclic T2∗ changes [84]. The contraction of the
heart muscle compresses the intramyocardial vasculature such
that inflow of arterial blood is interrupted while deoxygenated
blood is squeezed out of the myocardium toward the venous
coronary sinus [97–100] (Figure 12B). The major systolic
decrease in blood volume fraction in themyocardium reduces the
amount of deoxygenated hemoglobin per tissue volume, thereby
increasing—instead of lowering—T2∗ during systole. Previous
studies of skeletal muscle have also linked T2∗ changes to
alterations in tissue pH and resulting changes of the tissue water
content and distribution after exercise [101, 102]. These studies
have examined baseline and post-exercise conditions, which are
difficult to compare with the heart which is constantly exercising.
Still, T2 changes driven by tissue water content and distribution
changes should be considered as a potential source ofT2∗ changes
also in the heart. The hypothesis, that the observed periodic T2∗
changes could be induced by macroscopic B0 field variations
induced by changes in bulk morphology between systole and
diastole, was carefully investigated but not confirmed. Both, in
silico magneto static simulations and in vivo temporally resolved
B0 mapping, showed negligible impact of cardiac morphology on
the macroscopic B0 field in the ventricular septum and hence T2∗
[84].
Myocardial T2
∗ Mapping in Patients with
Cardiovascular Diseases
Besides the application of myocardial T2∗ mapping at ultrahigh
magnetic fields in healthy volunteers, first investigations were
carried out to explore the potential of the technique to
distinguish between healthy and pathologic myocardium. These
early UHF-CMR studies focused on T2∗ mapping in patients
with hypertrophic cardiomyopathy (HCM). HCM is the most
common inherited cardiac disease affecting about 0.2–0.5% of
the general population [103, 104]. The disease is characterized
by an increase in myocardial wall thickness related to myocyte
hypertrophy, microstructural changes like myocardial disarray,
fibrosis and microvascular dysfunction. HCM patients often
remain asymptomatic, but the disease can have a severe outcome
in a subgroup of patients where it may cause heart failure and
sudden unexpected cardiac death (SCD) in any age group. SCD
and has been reported to affect about 6% of HCM patients
within a mean follow up time of (8 ± 7) years [105]. This
renders risk stratification vital for HCM patients. CMR plays an
important role in the diagnosis and prognosis of HCM [106].
While a number of SCD risk factors in HCM have been identified
such as degree of hypertrophy or presence of fibrosis the task
remains challenging [107]. Consequently, basic research efforts
and clinical science activities are required to better characterize
HCM patient populations and to direct appropriate therapies to
those at risk.
Based on the structural and physiologic changes, differences
in myocardial T2∗ were hypothesized in HCM patients compared
to healthy controls. This hypothesis was investigated using high
spatiotemporal resolution T2∗ mapping at 7.0 T (Figure 13). It
was found that septal T2∗ is significantly increased in HCM with
mean septal T2∗ being (17.5 ± 1.4) ms in a cohort of HCM
patients compared to (13.7 ± 1.1) ms in a group of gender, age
and body mass index matched healthy controls. While variations
of myocardial T2∗ across the cardiac cycle have been attributed
to changes in myocardial blood volume fraction rather than
changes in tissue oxygenation [84], two main factors are assumed
to cause the observed overall T2∗ increase in HCM. Improved
tissue oxygenation in the diseased myocardium in the case of
HCM is unlikely. Instead, T2 has been reported to be elevated
in HCM [108] related to presence of inflammation and edema.
A T2 increase would also result in increased T2∗ as seen from
Equation (1). Further to this, reduced myocardial perfusion
and ischemia are common in HCM [109], effectively reducing
the tissue blood volume fraction resulting in a T2∗ increase as
suggested by Equation (5). These conditions are also associated
with a higher risk for a poor outcome in HCM patients [110].
With this in mind it is fair to conclude that myocardial T2∗
mapping could be beneficial for a better understanding of cardiac
(patho)physiology in vivo with the ultimate goal to support risk
stratification in HCM.
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FIGURE 12 | Results of temporally resolved myocardial T2
* mapping in healthy volunteers at 7.0 T. (A) Course of mean septal T2
*, wall thickness and LV inner radius
plotted over the cardiac cycle averaged for a group of healthy volunteers. Error bars indicate SD. Myocardial T2
* changes periodically across the cardiac cycle
increasing in systole and decreasing in diastole. (B) The periodic T2
* changes can be explained by cyclic variations of myocardial blood volume fraction related to
differences in blood pressure and myocardial wall stress. The massive pressure increase in the left ventricle in the beginning of systole results in high myocardial wall
stress compressing the myocardial vessels leading to a reduced blood supply to the myocardium while blood contained in the tissue is squeezed out. The resulting
reduced myocardial blood volume fraction explains the systolic T2
* increase, which cannot be explained by increased oxygenation.
CONCLUSION AND FUTURE DIRECTIONS
The progress in myocardial T2∗ mapping at ultrahigh magnetic
fields is promising [111–113]. Yet, there are still a number
of questions to be answered and the clinical benefit remains
to be carefully investigated. This requires further efforts to
tackle unsolved problems and unmet needs standing in the
way en route to broader clinical studies. For example, the
relatively long breath hold times required for the acquisition
of high spatiotemporal resolution T2∗ maps constitute a
challenge particularly in cardiac patients. Free breathing
acquisition techniques could offset this constraint permitting
broader application and full 3D heart coverage. This would
also help to further investigate the effect of through-plane
motion. Acquisition approaches like simultaneous multi-slice
excitation can be used to reduce scan times while multi-
channel transmit systems can be employed to balance excitation
field homogeneity and RF power deposition constraints [114,
115].
Based on the multifaceted contributions of physiological
parameters on T2∗ research will not stop at just mapping
myocardial T2∗. Tailored acquisition schemes, data post-
processing, analysis and interpretation will allow exploiting the
wealth of information encoded into T2∗. For example high spatial
resolution T2∗ mapping facilitated by ultrahigh magnetic field
strengths might be beneficial to gain a better insight into the
myocardial microstructure in vivo with the ultimate goal to
visualize myocardial fibers or to examine their helical angulation,
since the susceptibility effects depend on the orientation of blood
filled capillaries with regard to the external magnetic field [116].
Myocardial fiber tracking using T2∗ mapping holds the promise
to be less sensitive to bulk motion than diffusion-weighted MR of
the myocardium [117, 118]. The increased susceptibility contrast
available at 7.0 T could be exploited to quantitatively study
iron accumulation in the heart with high sensitivity and spatial
resolution superior to what can be achieved at 1.5 and 3.0 T. This
requires the determination of norm values for healthymyocardial
T2
∗ at 7.0 T as a mandatory precursor to broader clinical
studies.
At the same time small animal studies employing cardiac
disease models can provide a valuable contribution to
understanding the underlying biophysical principles and
(patho)physiological contrast mechanisms governing T2∗.
Unlike human studies they offer the unique possibility to directly
compare in vivo findings by MRI with ex vivo histology, the
gold standard for tissue characterization. Recent such studies
indicate that T2∗ might provide not only an alternative for
detection of both replacement and diffuse fibrosis without
the need for exogenous contrast agents, but also has potential
to distinguish the two by means of relaxation time changes
induced by the presence of collagen and other fibrotic elements
in the extracellular matrix [17, 18]. This could provide new
diagnostic means to a large group of patients excluded from
contrast agent injections due to renal insufficiencies. A study
employing a mouse myocardial ischemia/reperfusion model
has provided first insights into in vivo quantification of
T2
∗ changes in the mouse myocardium in relation to tissue
damage [16]. Local decrease of T2∗ was found in the infarct
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FIGURE 13 | Cardiac phase resolved myocardial T2
* mapping in healthy volunteers and HCM patients. (A) Temporally resolved myocardial T2
* maps of a short axis
view of a healthy control (top) and an HCM patient (bottom), (5 out of 20 phases shown). Spatial resolution (1.1 × 1.1 × 4.0) mm3. T2
* variations can be observed
across the cardiac cycle. (B) Course of mean septal T2
*, wall thickness and inner LV radius plotted over the cardiac cycle averaged for groups of healthy controls (left)
and HCM patients (right). Relative cardiac phase 0 indicates the beginning of systole. T2
* changes periodically over the cardiac cycle increasing in systole and
decreasing in diastole in both, healthy controls and HCM patients, but is significantly elevated in HCM patients.
zone and associated with deposition of collagen. The authors
describe that T2∗ varies dynamically during infarct development
suggesting that it may be used to discriminate between acute
and chronic infarctions. Taken together, by concordance the
findings between human studies and cardiac disease models of
small rodents will provide stronger evidence for fundamental
understandings of myocyte biology, and cardiac performance
with the goal to provide a more accurate diagnosis and risk
stratification. Thanks to the sensitivity gain at 7.0 T the spatial
fidelity feasible for T2∗ mapping in humans approaches the
relative anatomical spatial resolution—in terms of number
of voxels with respect to anatomy—demonstrated for cardiac
imaging in animal models [119, 120]. This achievement is
translatable into opportunities for discovery and translational
research.
The ability to probe for changes in myocardial tissue
oxygenation using T2∗ sensitized imaging/mapping offers the
potential to address some of the spatial and temporal resolution
constraints of conventional first pass perfusion imaging and
holds the promise to obviate the need for exogenous contrast
agents. Since microscopic susceptibility increases with field
strength, thus making oxygenation sensitivity due to ischemic
(patho) physiology more pronounced, T2∗ mapping at 7.0 T
might be beneficial to address some of the BOLD sensitivity
constraints reported for the assessment of regional myocardial
oxygenation changes in the presence of coronary artery
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stenosis [121] or for the characterization of vasodilator-induced
changes of myocardial oxygenation at 1.5 T and at 3.0 T
[10].
The pace of discovery is exciting and a powerful motivator
to transfer the lessons learned from T2∗ mapping research at
7.0 T into the clinical scenario. These efforts are fueled by the
quest for advancing the capabilities of quantitative MRI and
the wish to overcome the need of exogenous contrast agent
injections. The requirements of T2∗ mapping at 7.0 T are likely
to pave the way for further advances in MR technology and
MR systems design. With appropriate multi transmit systems
offering more than 16 transmit channels each providing at
least 4 kW peak power, an optimistically-inclined scientist
might envision the implementation of high density transceiver
arrays with 64 and more elements with the ultimate goal to
break ground for a many element upper torso or even a body
coil array. This vision continues to motivate new research on
integrated multi-channel transmission systems [122], on novel
RF pulse design, on RF coil design together with explorations
into ideal current patterns yielding optimal signal-to-noise-
ratio for UHF-CMR [123]. Perhaps another development is
the move toward myocardial T2∗ mapping using reduced field
of views zoomed into the target anatomy enabled by spatially
selective excitation techniques which put the capabilities of
parallel transmission technology to good use. With more than
45,000 examinations already performed at 7.0 T, the reasons for
employing UHF-MR in translational research and for moving
UHF-MR into clinical applications are more compelling than
ever. This provides strong motivation to put further weight
behind pushing the solution of the many remaining problems.
As an important step toward this goal a system manufacturer
has recently filed for FDA clearing for the clinical use of a
7.0 T system. With this development we can expect more
pioneering research institutions, university hospitals and large
clinics to become early adopters of CMR at 7.0 T and start
harvesting knowledge and know-how that will benefit clinical
applications.
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